Latest news with #non-GAAP
Business Wire
3 days ago
- Business
- Business Wire
Deadline Alert: 3D Systems Corporation (DDD) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP reminds investors of the upcoming deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the 'Class Period'). IF YOU SUFFERED A LOSS ON YOUR 3D SYSTEMS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS. What Happened? On March 26, 2025, 3D Systems released its fourth quarter and full year 2024 financial results, missing consensus estimates in non-GAAP earnings-per-share and sales revenue, citing 'lowers hardware systems sales due to macroeconomic factors that are negatively impacting demand.' The Company also reported a '$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program." The Company disclosed that "[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing . . . which led to refinement of the milestone technical criteria." On this news, 3D Systems' stock price fell $0.57, or 21%, to close at $2.15 per share on March 27, 2025, thereby injuring investors. Then, on May 12, 2025, after market hours, 3D Systems released its first quarter 2025 financial results, missing consensus estimates due, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. The Company further disclosed that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68, or 26.6%, to close at $1.87 per share on May 13, 2025, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired 3D Systems securities during the Class Period, you may move the Court no later than August 12, 2025 to request appointment as lead plaintiff in this putative class action lawsuit. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150, Toll-Free: 888-773-9224 Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. If you inquire by email, please include your mailing address, telephone number and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
4 days ago
- Business
- Yahoo
5 Revealing Analyst Questions From Insight Enterprises's Q1 Earnings Call
Insight Enterprises' first quarter results disappointed the market, as revenue declined year over year and missed Wall Street's expectations. Management cited delays in large enterprise services projects and a tough comparison from a major software transaction in the prior year as key factors impacting performance. CEO Joyce Mullen noted, 'Since our last earnings call, the outlook for the macro environment has deteriorated, resulting in increased volatility and uncertainty.' Despite these challenges, the company achieved its non-GAAP profitability targets through expense management and reported momentum in hardware demand. Is now the time to buy NSIT? Find out in our full research report (it's free). Revenue: $2.1 billion vs analyst estimates of $2.24 billion (11.6% year-on-year decline, 5.9% miss) Adjusted EPS: $2.06 vs analyst estimates of $2.01 (2.5% beat) Adjusted EBITDA: $111.3 million vs analyst estimates of $125 million (5.3% margin, 11% miss) Management reiterated its full-year Adjusted EPS guidance of $9.90 at the midpoint Operating Margin: 2.9%, down from 4.2% in the same quarter last year Market Capitalization: $4.22 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Joseph Cardoso (JPMorgan) asked what gives management confidence in reiterating guidance despite a tougher macro backdrop. CEO Joyce Mullen cited momentum in hardware, AI interest, and effective management of partner program changes as balancing factors. Joseph Cardoso (JPMorgan) also inquired about hardware demand trends and the impact of tariff threats. Mullen responded that only minimal demand pull-in was observed, mostly in devices, and emphasized that AI readiness is driving infrastructure upgrades. Adam Tindle (Raymond James) questioned how OEMs are responding to tariff announcements and potential impacts on pricing. Mullen said price increases have been limited and depend on supply chains, with the company generally able to pass on costs unless tariffs rise significantly. Adam Tindle (Raymond James) sought clarity on the services business decline. Mullen explained the lag between hardware recovery and services attachment and discussed retooling the consulting business using methodologies from recent acquisitions. Harry Read (Redburn) asked about the impact of Microsoft commission changes and recent headcount reductions. Mullen confirmed cloud performance was in line with expectations, and Morgado said the company will remain disciplined with expenses while preserving technical capacity. In upcoming quarters, the StockStory team will monitor (1) whether hardware momentum and device refresh cycles continue to offset slower services growth, (2) the pace of recovery in services revenue as delayed projects potentially resume, and (3) the company's ability to navigate tariff and supply chain pressures without further margin erosion. Progress on integrating AI and automation into the consulting business will also be a key signpost. Insight Enterprises currently trades at $135.17, down from $138.04 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Malaysian Reserve
4 days ago
- Business
- Malaysian Reserve
CTO Realty Growth, Inc. (CTO) Shares Decline Amid Wolfpack Report- Hagens Berman
CTO Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, June 26, 2025 /PRNewswire/ — On June 25, 2025 investors in CTO Realty Growth, Inc. (NYSE: CTO) saw the price of their shares significantly decline after Wolfpack Research published CTO: The B. Riley Of REITS, accusing CTO of misleading investors about its dividend sustainability and engaging in dubious financial activities. This report has prompted national shareholders rights firm Hagens Berman to open an investigation into the allegations and whether CTO may have violated the securities laws. The firm urges CTO investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Visit: Contact the Firm Now: CTO@ 844-916-0895 CTO Realty Growth, Inc. (CTO) Investigation: CTO represents itself as a 'self-managed equity REIT that focuses on the ownership, management, and repositioning of high-quality retail and mixed-use properties[.]' The investigation is focused on the propriety of CTO's assurances to investors that it adheres to applicable accounting rules and its use of certain non-GAAP accounting metrics. CTO's statements may have come into question on June 25, 2025, when Wolfpack published its report based, in part, on interviews with former employees and whistleblowers, in which it accuses CTO's management team of: '[L]ying to investors about the sustainability of their dividend while enriching themselves[;]' and '[E]ngag[ing] in accounting shenanigans like using a sham loan to cover up a top tenant's failure.' In contrast to CTO's assurances of 'high-quality retail and mixed-use' exposures, Wolfpack identified a subset of CTO properties in extreme financial distress and concluded that CTO is focused on buying and managing aging shopping centers, has not generated sufficient cash to pay its recurring capex, and relies on dilution to cover a $38 million dividend shortfall. The 'linchpin of management's deception,' according to Wolfpack, is its 'manipulative definition of Adjusted Funds From Operation (AFFO) where they exclude recurring capex, unlike all of their self-identified shopping center REIT peers[]' and management 'uses the same non-GAAP metric for 70% of its performance pay, inflating $8 million in bonuses we think they never should have received[.]' 'We're investigating whether CTO may have misled investors about the quality of its real estate portfolio, the reported asset values, and/or the propriety of its use of AFFO,' said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in CTO Realty Growth and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now » If you'd like more information and answers to frequently asked questions about the CTO investigation, read more » Whistleblowers: Persons with non-public information regarding CTO Realty Growth should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CTO@ About Hagens BermanHagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at Follow the firm for updates and news at @ClassActionLaw.
Business Wire
4 days ago
- Business
- Business Wire
Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results
1 These charges are recorded in Selling, general and administrative expenses and Impairment of goodwill within the Consolidated Condensed Statements of Earnings. The Company excludes these charges when evaluating operating performance because it does not incur such charges on a predictable basis and exclusion of such charges enables more consistent evaluation of the Company's operating performance. Impairment of goodwill, intangibles, and long-lived assets recognized in the nine months ended May 31, 2025 resulted from the interim goodwill impairment assessments for the VillageMD, U.S. Retail Pharmacy, and CareCentrix reporting units, as well as the intangible asset impairment for the Boots reporting unit and impairment of certain multi-year internal software development projects within the U.S. Retail Pharmacy segment. Impairment of goodwill, intangibles, and long-lived assets recognized in the nine months ended May 31, 2024 resulted from the interim goodwill impairment assessment for the VillageMD reporting unit and impairment of certain multi-year internal software development projects within the U.S. Retail Pharmacy segment. 2 Acquisition-related amortization includes amortization of acquisition-related intangible assets and stock-based compensation fair valuation adjustments. Amortization of acquisition-related intangible assets includes amortization of intangible assets such as customer relationships, provider networks, trade names, trademarks, developed technology and contract intangibles. Intangible asset amortization excluded from the related non-GAAP measure represents the entire amount recorded within the Company's GAAP financial statements. The revenue generated by the associated intangible assets has not been excluded from the related non-GAAP measures. Amortization expense, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired, or the estimated useful life of an intangible asset is revised. These charges are primarily recorded in Selling, general and administrative expenses within the Consolidated Condensed Statements of Earnings. The stock-based compensation fair valuation adjustment reflects the difference between the fair value based remeasurement of awards under purchase accounting and the grant date fair valuation. Post-acquisition compensation expense recognized in excess of the original grant date fair value of acquiree awards are excluded from the related non-GAAP measures as these arise from acquisition-related accounting requirements or agreements, and are not reflective of normal operating activities. 3 Certain legal and regulatory accruals and settlements relate to significant charges associated with certain legal proceedings, including legal defense costs. The Company excludes these charges when evaluating operating performance because it does not incur such charges on a predictable basis and exclusion of such charges enables more consistent evaluation of the Company's operating performance. These charges are recorded in Selling, general and administrative expenses within the Consolidated Condensed Statements of Earnings. 4 Footprint Optimization charges are costs associated with a formal restructuring plan. These charges are primarily recorded in Selling, general and administrative expenses within the Consolidated Condensed Statements of Earnings. These costs do not reflect current operating performance and are impacted by the timing of restructuring activity. 5 Acquisition and disposition-related costs are transaction and integration costs associated with certain merger, acquisition and divestitures related activities recorded in Selling, general and administrative expenses within the Consolidated Condensed Statements of Earnings. Examples of such costs include deal costs, severance, stock-based compensation, employee transaction success bonuses, and other integration related exit and disposal charges. These costs are significantly impacted by the timing and complexity of the underlying merger, acquisition and divestitures related activities and do not reflect the Company's current operating performance. In the three and nine months ended May 31, 2025, the Company recorded professional services and other transaction-related expenses of $15 million and $50 million, respectively, related to the merger agreement with Blazing Star Parent, LLC. As part of the amendment to the VillageMD Secured Loan executed in the three months ended November 30, 2024, Walgreen Co. and VillageMD agreed to terminate certain intercompany leases resulting in an early termination charge of $107 million incurred by VillageMD within the U.S. Healthcare segment and a corresponding gain recognized within the U.S. Retail Pharmacy segment. The impacts of the intercompany lease termination eliminate in consolidation. 6 Adjustments to equity earnings in Cencora consist of the Company's proportionate share of non-GAAP adjustments reported by Cencora consistent with the Company's non-GAAP measures. Adjustments are recorded to Equity earnings in Cencora within the Consolidated Condensed Statements of Earnings. 7 The Company's U.S. Retail Pharmacy segment inventory is accounted for using the last-in-first-out ('LIFO') method. This adjustment represents the impact on Cost of sales as if the U.S. Retail Pharmacy segment inventory is accounted for using first-in first-out ('FIFO') method. The LIFO provision is affected by changes in inventory quantities, product mix, and manufacturer pricing practices, which may be impacted by market and other external influences. Therefore, the Company cannot control the amounts recognized or timing of these items. These charges are recorded in Cost of sales within the Consolidated Condensed Statements of Earnings. 8 Transformational Cost Management Program charges are costs associated with a formal restructuring plan. These charges are primarily recorded in Selling, general and administrative expenses within the Consolidated Condensed Statements of Earnings. These costs do not reflect current operating performance and are impacted by the timing of restructuring activity. 9 Total non-cash impairment charges for goodwill and long-lived assets that were adjusted from Operating income (loss) were $115 million and $5.8 billion in the three and nine months ended May 31, 2025, respectively. Total non-cash impairment charges for goodwill and long-lived assets that were adjusted from Operating income (loss) were $23 million and $13.6 billion in the three and nine months ended May 31, 2024, respectively. 10 Includes fair value gains or losses on the VPF derivative contracts and gains on VPF settlements. These charges are recorded in Other income (expense), net, within the Consolidated Condensed Statements of Earnings. The Company does not believe this volatility related to the non-cash mark-to-market adjustments and associated settlement gains or losses on the underlying derivative instruments reflects the Company's operational performance. 11 Gains on the sale of equity method investments are recorded in Other income (expense), net within the Consolidated Condensed Statements of Earnings. The Company excludes these charges when evaluating operating performance because these do not relate to the ordinary course of the Company's business. 12 Includes significant gains resulting from the change in classification of equity securities as well as the fair value adjustments recorded on investments in equity securities to Other income (expense), net, in the Consolidated Condensed Statements of Earnings. In the three and nine months ended May 31, 2025, the Company recorded pre-tax gains of $10 million and $135 million related to the change in classification of its previously held equity method investment in BrightSpring to an investment in equity security held at fair value and subsequent related fair value adjustments. 13 Includes gains or losses related to the sale of businesses. These charges are recorded in Other income (expense), net, within the Consolidated Condensed Statements of Earnings. The Company excludes these charges when evaluating operating performance because these do not relate to the ordinary course of the Company's business. 14 Includes interest expense on certain multi-year litigation settlements and interest expense on external debt to fund incremental contributions to the Boots Plan required to complete the Trustee's acquisition of a bulk annuity policy (the 'Buy-In') from Legal & General. The payments and related incremental interest expense are not indicative of normal operating performance. 15 Adjustments to income tax provision (benefit) include adjustments to the GAAP basis tax provision (benefit) commensurate with non-GAAP adjustments and certain discrete tax items including U.S. and UK tax law changes and equity method non-cash tax. These charges are recorded in Income tax provision (benefit) within the Consolidated Condensed Statements of Earnings. 16 Adjustments to post-tax earnings (loss) from other equity method investments consist of the proportionate share of certain equity method investees' non-cash items or unusual or infrequent items consistent with the Company's non-GAAP adjustments. These charges are recorded in Post-tax earnings (loss) from other equity method investments within the Consolidated Condensed Statements of Earnings. Although the Company may have shareholder rights and board representation commensurate with its ownership interests in these equity method investees, adjustments relating to equity method investments are not intended to imply that the Company has direct control over their operations and resulting revenue and expenses. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all revenue and expenses of these equity method investees. 17 In the three months ended November 30, 2024, the Company and VillageMD executed an amendment to the VillageMD Secured Loan that consolidated certain VillageMD obligations to the Company, modified certain interest and fee terms, and provided VillageMD with additional borrowing capacity. These intercompany credit facilities eliminate in consolidation. The Company applies the legal claim approach to the attribution of intercompany transactions to non-controlling interests. The amendment of the VillageMD Secured Loan increased the Company's claim on VillageMD's net assets resulting in a pre-tax non-controlling interest benefit. The amendment and related one-time benefit to the Company are not indicative of normal operating performance. 18 Due to the anti-dilutive effect resulting from periods where the Company reports a net loss, the impact of potentially dilutive securities on the per share amounts has been omitted from the calculation of weighted-average common shares outstanding for diluted net loss per common share. 19 Includes impact of potentially dilutive securities from unvested stock-based compensation programs in the calculation of weighted-average common shares, diluted for adjusted diluted net earnings per common share calculation purposes. For the three months ended May 31, 2025, this impact of potentially dilutive securities in the calculation of weighted-average common shares was approximately 4 million shares. Excluding the impact of potentially dilutive securities, weighted-average basic and diluted common shares outstanding were approximately 865 million shares.
Yahoo
6 days ago
- Business
- Yahoo
APLD: A Turnaround in Profitability or Mirage Behind Adjusted EBITDA?
Applied Digital's APLD fiscal third-quarter 2025 results reflect a mixed bag of progress and persistent challenges, fueling a deeper debate over the company's ability to maintain consistent profitability. The 878% year-over-year jump in adjusted EBITDA (to $10 million) is indicative of its operational strength. However, the bottom-line GAAP reality tells a different story — a net loss of $36.1 million or 16 cents per share, which missed Street estimates by 5 cents. This widening gap between adjusted metrics and actual profitability has raised fresh concerns over the company's capital structure and earnings quality. Despite recording top-line revenue growth of 22% (totaling $52.9 million), APLD missed expectations by nearly $10 million. The quarter reflected operational hiccups, including technical issues transitioning its GPU clusters from single-tenant to a multi-tenant, on-demand model in the Cloud Services segment — an issue now resolved but responsible for revenue deceleration. Meanwhile, the Data Center Hosting segment experienced margin compression due to seasonal power cost increases. Strategically, Applied Digital made bold moves with financing partnerships — securing a $5 billion capital commitment from Macquarie and a $375 million loan from SMBC — strengthening its liquidity for the Ellendale campus buildout. However, the company also announced that it is reviewing strategic alternatives for its AI Cloud Services business, citing conflict with hyperscaler leasing prospects and potential REIT conversion benefits. With a rising debt load of $689.1 million and mounting interest expenses, investors are increasingly assessing whether Applied Digital's growth is self-sustaining or overly reliant on adjusted metrics and leveraged financing. As management eyes a potential sale of its AI business and continues to push aggressive campus expansion, the fundamental question looms: Is this a genuine turnaround or simply a mirage created by non-GAAP profitability optics? The answer may shape the next leg of APLD's market narrative. Core Scientific CORZ reported first-quarter 2025 revenues of $79.5 million, reflecting a sharp 55.6% year-over-year decline. This is indicative of the continued challenges in the crypto mining environment. The company posted an operating loss of $42.6 million, and adjusted EBITDA swung to a negative $6.1 million from $88 million in the prior-year period. While GAAP net income turned positive due to a $621.5 million non-cash gain related to warrants, core operations remained under pressure. The results highlight Core Scientific's transitional phase post-bankruptcy, as it works to stabilize operations amid fluctuating Bitcoin prices and elevated energy costs that continue to compress mining margins. Marathon Digital MARA reported first-quarter 2025 revenues of approximately $214 million, marking a 30% year-over-year increase. Despite strong top-line growth and a nearly doubled hashrate reaching 54.3 EH/s, the company posted a net loss of $533 million, or $1.55 per share. The loss was primarily due to a $552 million non-cash fair value adjustment on digital assets and derivative instruments. Adjusted EBITDA also turned negative at $484 million. The top and bottom-line figures missed analyst expectations, raising concerns about volatility in crypto asset valuations and its impact on Marathon's bottom line despite ongoing operational expansion. Shares of APLD have surged 29.2% in the year-to-date period against the industry's decline of 3.7%. Image Source: Zacks Investment Research From a valuation standpoint, Applied Digital trades at a forward price-to-sales ratio of 8.97X, above the industry average as well as its five-year median of 1.44X. APLD carries a Value Score of F. Image Source: Zacks Investment Research The Zacks Consensus Estimate for Applied Digitals' fiscal 2026 earnings implies a 73.6% rise year over year. Image Source: Zacks Investment Research The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Marathon Digital Holdings, Inc. (MARA) : Free Stock Analysis Report Applied Digital Corporation (APLD) : Free Stock Analysis Report Core Scientific, Inc. (CORZ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
